Alifah Evi Scania
Research Subjects
Alifah Evi Scania has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Dewi Ranggaini
Department of Physiology, Division of Oral Biology, Faculty of Dentistry, Universitas Trisakti, Jl. Kyai Tapa No. 260, Jakarta, 11440, Indonesia
2 shared publications- Ferry Sandra
Department of Biochemistry and Molecular Biology, Division of Oral Biology, Faculty of Dentistry, Universitas Trisakti, Jakarta, Indonesia
2 shared publications Alfred Pakpahan
Department of Biology, Division of Oral Biology, Faculty of Dentistry, Universitas Trisakti, Jl. Kyai Tapa No. 260, Jakarta, 11440, Indonesia
1 shared publicationBoedi Oetomo Roeslan
Department of Biochemistry and Molecular Biology, Division of Oral Biology, Faculty of Dentistry, Universitas Trisakti, Jl. Kyai Tapa No. 260, Jakarta 11440
1 shared publicationElizabeth Yuliani Taramalinda
Faculty of Dentistry, Universitas Trisakti, Jl. Kyai Tapa No. 260, Jakarta 11440
1 shared publication- Fera Ibrahim
Department of Microbiology Faculty of Medicine Universitas Indonesia / Dr. Cipto Mangunkusumo Hospital, Pegangsaan Timur 16 Street, East Jakarta, 10430, Indonesia
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1)
Coevolution of Human Diet and Gut Microbiome: Implications for Nutrigenomics and Cross‐Population Health
The coevolution of the human diet and gut microbiome has played a pivotal role in shaping metabolic, immune, and epigenetic functions across human history. Dietary transitions from high‐fiber ancestral patterns to modern ultraprocessed diets have markedly influenced microbial diversity and functionality, contributing to the emergence of chronic diseases such as obesity, Type 2 diabetes, and inflammatory conditions. Recognizing the significance of gut microbial patterns in humans, this review explores the coevolution of diet and gut microbiota, especially on how gut microbiota influences human gene regulation, and the implications of these interactions for personalized nutrition and global health strategies. Comparative insights across populations in different periods reveal that geography, dietary practices, and host genetics interact to shape distinct microbiome configurations and disease susceptibility. Therefore, implementing a nutrigenomics and nutrigenetics approach might provide a molecular framework to understand these interactions and to develop personalized nutrition strategies. Though several clinical implementations utilizing genomic data have been embedded in several countries, global implementation remains challenging due to population‐specific genetic variability, cultural dietary preferences, cost limitations, and ethical considerations. Integrating microbiome and genetic data into clinical practice and public health policy offers a promising path to mitigate diet‐related health disparities that is tailored to individual and population‐level needs.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1)
Open AccessCoevolution of Human Diet and Gut Microbiome: Implications for Nutrigenomics and Cross‐Population Health
The coevolution of the human diet and gut microbiome has played a pivotal role in shaping metabolic, immune, and epigenetic functions across human history. Dietary transitions from high‐fiber ancestral patterns to modern ultraprocessed diets have markedly influenced microbial diversity and functionality, contributing to the emergence of chronic diseases such as obesity, Type 2 diabetes, and inflammatory conditions. Recognizing the significance of gut microbial patterns in humans, this review explores the coevolution of diet and gut microbiota, especially on how gut microbiota influences human gene regulation, and the implications of these interactions for personalized nutrition and global health strategies. Comparative insights across populations in different periods reveal that geography, dietary practices, and host genetics interact to shape distinct microbiome configurations and disease susceptibility. Therefore, implementing a nutrigenomics and nutrigenetics approach might provide a molecular framework to understand these interactions and to develop personalized nutrition strategies. Though several clinical implementations utilizing genomic data have been embedded in several countries, global implementation remains challenging due to population‐specific genetic variability, cultural dietary preferences, cost limitations, and ethical considerations. Integrating microbiome and genetic data into clinical practice and public health policy offers a promising path to mitigate diet‐related health disparities that is tailored to individual and population‐level needs.
- Open Access
- 28 October 2024
- Published by Secretariat of The Indonesian Biomedical Journal in The Indonesian Biomedical Journal
- Vol. 16 (5) , 473-80
Stenochlaena palustris Ethanol Extract Decreases Viability and Induces G1-Phase Cell Cycle Arrest in HSC-3 Tongue Cancer Cells via p21 and p27
BACKGROUND: Oral squamous cell carcinoma (OSCC) of the tongue is an aggressive cancer with a poor prognosis due to its resistance to standard treatments. Stenochlaena palustris, a medicinal fern containing bioactive compounds, has shown potential anticancer properties. However, there is a lack of studies addressing the effects of S. palustris ethanol extract (SPEE) on tongue cancer. This study examined the effects of SPEE on the cell viability and cell cycle of human squamous cell carcinoma (HSC)-3 tongue cancer cells.METHODS: SPEE was prepared with the maceration method. HSC-3 cells were treated with SPEE at concentrations of 100, 500, and 1000 µg/mL for 24 and 48 hours. Cell viability was measured with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell cycle analysis was performed using flow cytometer. Immunoblotting was used to measure amount of cell cycle regulators, protein 21 (p21) and protein 27 (p27).RESULTS: SPEE treatment led to a significant decrease in HSC-3 viable cells in a concentration- and time-dependent manner, with the most pronounced effect at higher concentration and prolonged treatment time. There was a slightly increase in the percentage of cells in the Sub-G1 phase in SPEE-treated group, meanwhile there was a significant increase in the percentage of cells in the G1-phase. Increased amount of p21 and p27 were observed in SPEE-treated group.CONCLUSION: SPEE significantly inhibited HSC-3 cell proliferation in a concentration- and time-dependent manner, primarily by inducing G1-phase cell cycle arrest through the upregulation of p21 and p27. Taken together, SPEE could be a potential anti-cancer agent for tongue cancer cell. KEYWORDS: Stenochlaena palustris, tongue cancer, cytotoxic, cell cycle arrest, HSC-3 cells, p21, p27
- 28 October 2024
- Published by Secretariat of The Indonesian Biomedical Journal in The Indonesian Biomedical Journal
- Vol. 16 (5) , 473-80
Open AccessStenochlaena palustris Ethanol Extract Decreases Viability and Induces G1-Phase Cell Cycle Arrest in HSC-3 Tongue Cancer Cells via p21 and p27
BACKGROUND: Oral squamous cell carcinoma (OSCC) of the tongue is an aggressive cancer with a poor prognosis due to its resistance to standard treatments. Stenochlaena palustris, a medicinal fern containing bioactive compounds, has shown potential anticancer properties. However, there is a lack of studies addressing the effects of S. palustris ethanol extract (SPEE) on tongue cancer. This study examined the effects of SPEE on the cell viability and cell cycle of human squamous cell carcinoma (HSC)-3 tongue cancer cells.METHODS: SPEE was prepared with the maceration method. HSC-3 cells were treated with SPEE at concentrations of 100, 500, and 1000 µg/mL for 24 and 48 hours. Cell viability was measured with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell cycle analysis was performed using flow cytometer. Immunoblotting was used to measure amount of cell cycle regulators, protein 21 (p21) and protein 27 (p27).RESULTS: SPEE treatment led to a significant decrease in HSC-3 viable cells in a concentration- and time-dependent manner, with the most pronounced effect at higher concentration and prolonged treatment time. There was a slightly increase in the percentage of cells in the Sub-G1 phase in SPEE-treated group, meanwhile there was a significant increase in the percentage of cells in the G1-phase. Increased amount of p21 and p27 were observed in SPEE-treated group.CONCLUSION: SPEE significantly inhibited HSC-3 cell proliferation in a concentration- and time-dependent manner, primarily by inducing G1-phase cell cycle arrest through the upregulation of p21 and p27. Taken together, SPEE could be a potential anti-cancer agent for tongue cancer cell. KEYWORDS: Stenochlaena palustris, tongue cancer, cytotoxic, cell cycle arrest, HSC-3 cells, p21, p27
- 27 August 2024
- Published by Universitas Islam Indonesia (Islamic University of Indonesia) in Jurnal Kedokteran dan Kesehatan Indonesia
- p. 257-264
Potential of endophytic bacteria as producers of antibiotics: A literature review
Microbial infection is a significant contributing aspect to the development of diseases, posing ongoing challenges in - healthcare. Numerous synthetic antibiotic agents have been used as therapeutic interventions; however, many microorganisms exhibit resistance to these synthetic agents. The rate at which microbes developed resistance to antibiotics has outpaced the discoveries and study of new treatments. The potential of endophytic bacteria to produce bioactive compounds or metabolites that can serve as the basis for developing new antibiotic drugs is promising is promising. This review aims to explore the metabolite potential of endophytic bacteria as a source of antibiotics. Understanding the mechanism and potential of endophytic bacteria offers opportunities for the advancing therapeutic interventions to mitigate the negative effects of various strains of antibiotic-resistant pathogenic bacteria.
- 27 August 2024
- Published by Universitas Islam Indonesia (Islamic University of Indonesia) in Jurnal Kedokteran dan Kesehatan Indonesia
- p. 257-264
Potential of endophytic bacteria as producers of antibiotics: A literature review
Microbial infection is a significant contributing aspect to the development of diseases, posing ongoing challenges in - healthcare. Numerous synthetic antibiotic agents have been used as therapeutic interventions; however, many microorganisms exhibit resistance to these synthetic agents. The rate at which microbes developed resistance to antibiotics has outpaced the discoveries and study of new treatments. The potential of endophytic bacteria to produce bioactive compounds or metabolites that can serve as the basis for developing new antibiotic drugs is promising is promising. This review aims to explore the metabolite potential of endophytic bacteria as a source of antibiotics. Understanding the mechanism and potential of endophytic bacteria offers opportunities for the advancing therapeutic interventions to mitigate the negative effects of various strains of antibiotic-resistant pathogenic bacteria.